Glucosamine sulfate
Arthryl and VIARTRIL-S are different trade names for the same medicine.
Arthryl is used to treat symptoms of mild or moderate knee osteoarthritis.
The medicine should not be used in children.
Tell your doctor about all the medicines you are taking now or have taken recently, including those that are available without a prescription, as well as any medicines you plan to take.
During clinical trials, no interactions were observed between glucosamine sulfate and other medicines.
Cautious use is recommended when taking Arthryl in combination with other medicines, particularly certain types of medicines used to prevent blood clotting (e.g., warfarin, dicumarol, phenprocoumon, acenocoumarol, and fluindion). The effect of these medicines may be stronger when taken with glucosamine. Patients treated with such combinations of medicines should be closely monitored when starting or stopping glucosamine treatment.
During glucosamine sulfate treatment, non-steroidal anti-inflammatory and pain-relieving medicines can be taken at the same time.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before taking this medicine.
Data on the effect of glucosamine sulfate on fertility and lactation from animal studies are insufficient. There are no adequate data on the use of glucosamine in pregnant or breastfeeding women.
The medicine should not be used during pregnancy.
Using the medicine during breastfeeding is not recommended, as there are no data on its safety in newborns.
Arthryl does not significantly affect the ability to drive or use machines. However, caution is recommended in case of headache, drowsiness, fatigue, dizziness, or vision disturbances.
The medicine contains 2.5 mg of aspartame (E 951) per sachet. Aspartame is a source of phenylalanine.
It may be harmful to patients with phenylketonuria. This is a rare genetic disorder in which phenylalanine accumulates in the body due to its improper excretion.
The medicine contains 2028.5 mg of sorbitol (E 420) per sachet. Sorbitol is a source of fructose. If you have previously been diagnosed with intolerance to some sugars or have hereditary fructose intolerance, a rare genetic disorder in which the body does not break down fructose, you should consult your doctor before taking the medicine.
The medicine contains 6.6 mmol (151 mg) of sodium (the main component of common salt) per sachet.
This corresponds to 7.6% of the maximum recommended daily intake of sodium in the diet for adults. Patients controlling their sodium intake should take this into account.
Take this medicine always as directed by your doctor. If you are unsure, consult your doctor or pharmacist.
The contents of one sachet dissolved in a glass of water should be taken once a day, preferably with a meal.
No cases of overdose have been reported so far. The results of animal studies indicate that the occurrence of toxic effects is unlikely even after taking very high doses of the medicine.
Do not take a double dose to make up for a missed dose. Take the next dose at the normal time.
Do not stop treatment without consulting your doctor. If you have any further doubts about taking this medicine, consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Clinical trials have shown that the medicine is well-tolerated. Side effects were observed in a small number of patients. They were usually transient and mild.
The observed side effects are divided according to the following frequency:
Gastrointestinal disorders:abdominal pain, nausea, bloating, constipation, diarrhea, or indigestion.
Nervous system disorders:headache, drowsiness.
Vascular disorders:flushing, especially of the face.
General disorders and administration site conditions:fatigue.
Skin and subcutaneous tissue disorders:rash, itching, urticaria.
Immune system disorders:allergic reactions (hypersensitivity).
Metabolism and nutrition disorders:inadequate control of blood glucose levels in patients with diabetes.
Psychiatric disorders:insomnia.
Nervous system disorders:dizziness.
Eye disorders:vision disturbances.
Cardiac disorders:arrhythmias, e.g., tachycardia (accelerated heart rate).
Respiratory, thoracic, and mediastinal disorders:asthma or exacerbation of asthma.
Gastrointestinal disorders:vomiting.
Hepatobiliary disorders:jaundice.
Skin and subcutaneous tissue disorders:angioedema, urticaria.
General disorders and administration site conditions:edema or peripheral edema.
Investigations:increased liver enzyme activity, increased blood glucose levels, fluctuations in INR (International Normalized Ratio, a measure of blood clotting).
Cases of hypercholesterolemia have been reported, but their connection to the use of the medicine has not been demonstrated.
If you experience any side effects, including any side effects not listed in the leaflet, you should tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Aleje Jerozolimskie 181C, 02-222 Warsaw
phone: 22 49-21-301, fax: 22 49-21-309
website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help gather more information on the safety of the medicine.
Keep the medicine out of the sight and reach of children.
Store in a temperature below 25°C.
Do not use the medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of the medicine is glucosamine sulfate.
One sachet contains 1500 mg of glucosamine sulfate (Glucosamini sulfas) in the form of 1884 mg of glucosamine sulfate with sodium chloride.
The other ingredients of the medicine are: aspartame (see also the subsection "Arthryl contains aspartame" in section 2), sorbitol (see also the subsection "Arthryl contains sorbitol" in section 2), macrogol 4000, citric acid.
White, crystalline, odorless powder for oral solution in a sachet containing one dose of the medicine.
A cardboard box contains 20 or 30 sachets.
For more detailed information, consult the marketing authorization holder or the parallel importer.
BGP Products, Unipessoal Lda., Av. D. João II, Edifício Atlantis, nº 44C – 7.3 e 7. 4, 1990-095
Lisbon, Portugal
Rottapharm Ltd.
Damastown, Industrial Park, Mulhuddart, Dublin 15, Ireland
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Portuguese marketing authorization number: 2799286
5122684
5005277
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.